003850 — Boryung Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual income statement for Boryung, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	561,867	627,279	760,476	859,626	1,017,107
Cost of Revenue
Gross Profit	231,442	264,937	307,187	353,430	363,357
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	521,800	585,831	705,480	791,359	952,687
Operating Profit	40,067	41,448	54,996	68,267	64,419
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	36,044	70,718	58,872	56,306	62,959
Provision for Income Taxes
Net Income After Taxes	26,860	43,119	41,938	40,213	69,636
Minority Interest
Net Income Before Extraordinary Items
Net Income	26,856	43,044	41,894	40,203	69,633
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	26,856	43,044	41,894	40,203	69,633
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	448	687	655	612	1,074
Dividends per Share